Yahoo Web Search

Search results

  1. David Alain Wohl is an American infectious disease physician. During the COVID-19 pandemic, he was among those leading UNC's response to the SARS-CoV-2 pandemic.Wohl was appointed the Medical Director of the COVID Vaccination Clinic at UNC Hospitals Hillsborough Campus and led COVID-19 treatment clinical trials at UNC School of Medicine.

  2. Dr. Wohl is a Professor of Medicine in the Division of Infectious Diseases at the University of North Carolina (UNC). He is co-Principal Investigator of the Global UNC Infectious Diseases Clinical Trials Unit and Site Leader of its Chapel Hill research site. Dr. Wohl is a clinical scientist with a focus on emergent infectious diseases. He has ...

  3. David Alain Wohl, M.D., is a professor of medicine in the Division of Infectious Diseases at the University of North Carolina (UNC). He is site leader of the UNC AIDS Clinical Trials Unit at ...

  4. Sep 1, 2020 · David Wohl, MD, is principal investigator for the COVID-19 treatments trial beginning at UNC . UNC Institute for Global Health and Infectious Diseases researchers have begun phase 2 and phase 3 evaluations of promising treatments for COVID-19. The UNC School of Medicine joins more than 25 initial sites participating in the clinical trials through ACTIV-2, a public-private partnership sponsored ...

  5. Nov 30, 2020 · David Alain Wohl, M.D., Professor of Medicine, Division of Infectious Diseases sanjagrujic via iStock As 2020 draws to a close, we asked David Alain Wohl, M.D., a professor of medicine in the Division of Infectious Diseases at the University of North Carolina and a highly respected HIV clinician-researcher, to take stock of the year's most momentous research developments and other critical events.

  6. Apr 12, 2024 · David Alain Wohl, John R Koethe, Paul E Sax, Grace A McComsey, Daniel R Kuritzkes, Graeme Moyle, Lee Kaplan, Jean van Wyk, Rafael E Campo, Calvin Cohen, ...

  7. People also ask

  8. Jul 19, 2019 · David Alain Wohl, MD, is a Professor of Medicine in the Division of Infectious Diseases at the University of North Carolina and is the Site Leader of the UNC Global HIV Prevention and Treatment Clinical Research Unit at Chapel Hill. In 2014, he co-founded the UNC Viral Hemorrhagic Fever Research Group.

  1. People also search for